- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Newbridge Securities Corporation today announced the quarterly rebalancing and reconstitution of its Newbridge Nanotechnology Index (NYSE Arca: NNIX). This quarter saw no additions or deletions among the constituents, leaving the total number of companies included at 24. Constituents subject to the 10% index weight cap were Headwaters (NYSE: HW), FEI Co. (NASDAQ: FEIC), Amcol (NYSE: ACO), and Symyx Technologies (NASDAQ: SMMX). The NNIX ended the quarterly period at 900.07, up 1.9% from the last rebalance on November 17, 2006.
The Newbridge Nanotechnology Index (NNIX) has been constructed to track the stock market performance of companies that are currently active in nanotechnology. The Index is comprised of companies whose operations, based on our assessment of products, intellectual property, research initiatives and partnerships, include a significant focus on nanotechnology. Companies whose market capitalizations are very large relative to the scope of their nanotechnology operations are not included in order to preserve the "pure play" nature of the Index. Only companies with common stock or ADRs listed on a national market or exchange in the U.S. are eligible. The base date for the Index was June 30, 2004, at which time the base value for the Index was set at 1000. The NNIX is market cap weighted, rebalanced quarterly, and now includes 24 companies.
About Newbridge Securities Corporation
Newbridge is a full-service securities brokerage firm (Member: NASD & SIPC) and a subsidiary of Newbridge Financial, Inc., an integrated financial services company. The Newbridge Institutional Research department specializes in the analysis and coverage of companies that have a strategic focus on nanotechnology. More information is available at our websites http://www.newbridgereports.com and http://www.newbridgesecurities.com .
For important disclosures please visit: http://www.newbridgesecurities.com/research_rpt_discl.html. Additional information is available upon request.
For more information, please click here
David M. Keiter
Director of Research
Copyright © Market WireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Nanotech Grants Options September 22nd, 2016
Arrowhead Pharmaceuticals to Present at Upcoming September Conferences September 1st, 2016
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Chad Mirkin receives nanotechnology prize in Russia October 26th, 2016
Imaging where cancer drugs go in the body could improve treatment October 26th, 2016